Newborn screening is used to detect in babies congenital diseases that are treatable only when identified during the first days of life. PerkinElmer supplies all of the products needed to establish and maintain an effective screening program.
Biotinidase (BTD) deficiency
Congenital adrenal hyperplasia (CAH)
Congenital Hypothyroidism
Congenital Toxoplasmosis
Cystic fibrosis (CF)
Galactosemia
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Hemoglobinopathy
Instrument Platforms
MSMS Reagents
Phenylketonuria (PKU)
Software
Top of page